首页> 外文会议>SPIE Conference on Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications >Ultrasmall visible-to-near-infrared emitting silver-sulfide quantum dots for cancer detection and imaging
【24h】

Ultrasmall visible-to-near-infrared emitting silver-sulfide quantum dots for cancer detection and imaging

机译:超大可见近乎红外线发射氧硫化物量子点,用于癌症检测和成像

获取原文

摘要

The large size of many near infrared (NIR) fluorescent nanoparticles prevents rapid extravasation from blood vessels and subsequent diffusion to tumors. This confines in vivo uptake to the peritumoral space and results in high liver retention. We developed a viscosity modulated approach to synthesize ultrasmall silver sulfide quantum dots (QDs) with distinct tunable light emission from visible to near-infrared in spectrum and a QD core diameter between less than 5 nm. Further functionalization of these Ag_2S QDs with different type of molecules such as targeting peptides, retains monodisperse, relatively small water soluble QDs without loss of the functionality of the peptide's high binding affinity to cancerous tumor. Fluorescence and electron microscopy showed that selective integrin-mediated internalization was observed only in cancer cells treated with the peptide-labeled QDs, demonstrating that the unlabeled hydrophilic nanoparticles exhibit characteristics of negatively charged fluorescent dye molecules, which typically do not internalize in cells. The biodistribution profiles of intravenously administered QDs in different mouse models of cancer reveal an exceptionally high tumor-to-liver uptake ratio, suggesting that the small sized QDs evaded conventional opsonization and subsequent high uptake in the liver and spleen. The seamless tunability of the QDs over a wide spectral range with only a small increase in size, as well as the ease of labeling the bright and non-cytotoxic QDs with biomolecules, provides a platform for multiplexing information, tracking the trafficking of single molecules in cells, and selectively targeting disease biomarkers in living organisms without premature QD opsonization in circulating blood.
机译:许多近红外(NIR)荧光纳米粒子的大尺寸可防止血管快速进入和随后扩散到肿瘤。这限制了体内吸收到蠕动空间,并导致高肝脏保留。我们开发了一种粘度调节方法,以合成具有从光谱附近的明显可调谐的光发射的超微储物硫化物量子点(QDS),并且在小于5nm之间的QD芯直径之间可见。通过不同类型的分子如靶向肽的进一步官能化,例如靶向肽,保留单分散,相对小的水溶性QD,而不会损失肽对癌肿瘤的高结合亲和力的功能。荧光和电子显微镜表明,仅在用肽标记的QD处理的癌细胞中观察到选择性整合型内化,证明未标记的亲水纳米颗粒表现出负电荷的荧光染料分子的特征,其通常不会在细胞中内化。在不同小鼠癌症模型中静脉内施用的QD的生物分布曲线揭示了特殊的肿瘤到肝脏吸收率,这表明小尺寸的QD脱落了常规的Opson化和随后在肝脏和脾脏的高吸收。 QDS在宽谱范围内的无缝可调性,只有小的尺寸增加,以及与生物分子的明亮和非细胞毒性QDS的易于标记,提供了用于复用信息的平台,跟踪单个分子的贩运细胞,并选择性地靶向生物体中的疾病生物标志物,没有早熟的QD OPSON化在循环血液中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号